1 |
LIYANAGE T, NINOMIYA T, JHA V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review[J]. Lancet, 2015, 385(9981):1975-1982. DOI:10.1016/S0140-6736(14)61601-9 .
|
2 |
ROOIJENS P P G M, TORDOIR J H M, STIJNEN T, et al. Radiocephalic wrist arteriovenous fistula for hemodialysis: meta-analysis indicates a high primary failure rate[J]. Eur J Vasc Endovasc Surg, 2004, 28(6):583-589. DOI: 10.1016/j.ejvs.2004.08.014 .
|
3 |
HUIJBREGTS H J T, BOTS M L, WITTENS C H A, et al. Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative[J]. Clin J Am Soc Nephrol, 2008, 3(3):714-719. DOI: 10.2215/CJN.02950707 .
|
4 |
AL-JAISHI A A, OLIVER M J, THOMAS S M, et al. Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis[J]. Am J Kidney Dis, 2014, 63(3):464-478. DOI: 10.1053/j.ajkd.2013.08.023 .
|
5 |
WASSE H, HUANG R, NAQVI N, et al. Inflammation, oxidation and venous neointimal hyperplasia precede vascular injury from AVF creation in CKD patients[J]. J Vasc Access, 2012, 13(2):168-174. DOI: 10.5301/jva.5000024 .
|
6 |
ROY-CHAUDHURY P, WANG Y, KRISHNAMOORTHY M, et al. Cellular phenotypes in human stenotic lesions from haemodialysis vascular access[J]. Nephrol Dial Transplant, 2009, 24(9):2786-2791. DOI: 10.1093/ndt/gfn708 .
|
7 |
ROY-CHAUDHURY P, AREND L, ZHANG J H, et al. Neointimal hyperplasia in early arteriovenous fistula failure[J]. Am J Kidney Dis, 2007, 50(5):782-790. DOI: 10.1053/j.ajkd. 2007. 07. 019 .
|
8 |
YANG B X, SHERGILL U, FU A A, et al. The mouse arteriovenous fistula model[J]. J Vasc Interv Radiol, 2009, 20(7):946-950. DOI: 10.1016/j.jvir.2009.03.044 .
|
9 |
YAMAMOTO K, PROTACK C D, TSUNEKI M, et al. The mouse aortocaval fistula recapitulates human arteriovenous fistula maturation[J]. Am J Physiol Heart Circ Physiol, 2013, 305(12): H1718-H1725. DOI: 10.1152/ajpheart.00590.2013 .
|
10 |
LIANG M, WANG Y, LIANG A L, et al. Migration of smooth muscle cells from the arterial anastomosis of arteriovenous fistulas requires Notch activation to form neointima[J]. Kidney Int, 2015, 88(3):490-502. DOI: 10.1038/ki.2015.73 .
|
11 |
MISRA S, KILARI S, YANG B X, et al. Anti human CX3CR1 VHH molecule attenuates venous neointimal hyperplasia of arteriovenous fistula in mouse model[J]. J Am Soc Nephrol, 2021, 32(7):1630-1648. DOI: 10.1681/ASN.2020101458 .
|
12 |
CAI C Q, KILARI S, ZHAO C L, et al. Therapeutic effect of adipose derived mesenchymal stem cell transplantation in reducing restenosis in a murine angioplasty model[J]. J Am Soc Nephrol, 2020, 31(8):1781-1795. DOI: 10.1681/ASN. 2019101042 .
|
13 |
ROY-CHAUDHURY P, KHAN R, CAMPOS B, et al. Pathogenetic role for early focal macrophage infiltration in a pig model of arteriovenous fistula (AVF) stenosis[J]. J Vasc Access, 2014, 15(1):25-28. DOI: 10.5301/jva.5000151 .
|
14 |
CHAN J S, CAMPOS B, WANG Y, et al. Proliferation patterns in a pig model of AV fistula stenosis: can we translate biology into novel therapies?[J]. Semin Dial, 2014, 27(6):626-632. DOI: 10.1111/sdi.12240 .
|
15 |
KOKOZIDOU M, KATSARGYRIS A, VERHOEVEN E L G, et al. Vascular access animal models used in research[J]. Ann Anat Anat Anz, 2019, 225:65-75. DOI: 10.1016/j.aanat.2019.06.002 .
|
16 |
FLORESCU M C, FOSTER K W, SACKS A R, et al. Sheep model of hemodialysis arteriovenous fistula using superficial veins[J]. Semin Dial, 2015, 28(6):687-691. DOI: 10.1111/sdi.12407 .
|
17 |
CASTIER Y, LEHOUX S, HU Y, et al. Characterization of neointima lesions associated with arteriovenous fistulas in a mouse model[J]. Kidney Int, 2006, 70(2):315-320. DOI: 10.1038/sj.ki.5001569 .
|
18 |
CAI C Q, ZHAO C L, KILARI S, et al. Experimental murine arteriovenous fistula model to study restenosis after transluminal angioplasty[J]. Lab Anim, 2020, 49(11):320-334. DOI: 10.1038/s41684-020-00659-x .
|